Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
18 October 2022 | Story Tsholo Maleho
UFS librarian Nambitha Manqola
UFS librarian Nambitha Manqola received top honours at the 2022 Library and Information Association of South Africa conference, scooping the association’s Emerging Librarian Award.

The University of the Free State Library and Information Services (UFS LIS) continues to deliver world-class services, with its staff members receiving national accolades.

Highlighting the library’s positive contributions, Nambitha Manqola, Chief Officer in the UFS LIS on the Bloemfontein Campus, recently scooped the Library and Information Association of South Africa (LIASA) - Nevada LMS Emerging Librarian Award at the association’s national conference hosted in Gauteng from 4 to 7 October 2022.

 

A role model for the Library and Information Services community

This award is given to someone who demonstrates characteristics indicating that they are a role model for the library and information services community, someone whose contributions could have a long-term impact on the sector, and someone who will be an ambassador for LIASA, Nevada LMS, and librarianship in the coming years, including embracing the post-modern digital landscape.

This accolade recognises the achievements and accomplishments of emerging, inspiring, and exceptional public, academic, school, and special librarians who have earned their LIS qualification within the past five years.

Manqola is known throughout the UFS LIS and Free State library community as a well-rounded individual who is gifted and skilled in a variety of areas, particularly technology. She is based in the UFS LIS Digital Scholarship Centre and is responsible for research data management, and library systems.

Her contribution to the UFS library's growth and marketing, especially during the COVID-19 pandemic, has left a lasting impression, making her an ambassador for how library professionals should embrace change and technology.

News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept